Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: A Belgian retrospective multicentre study

Dear Editor, We read with great interest the multicenter and retrospective study of Fougerosse et al1 that investigated real-life effectiveness and tolerance of guselkumab at week 16 in the treatment of cutaneous psoriasis. In the same manner, we conducted the first multicenter study in Belgium aiming to investigate real-life effectiveness and tolerance of guselkumab at week 16 in the treatment of cutaneous psoriasis. [.]